
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152543E98AF2EFB30543E90062D9D116.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ejnmmiradchem">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="EJNMMI Radiopharmacy and Chemistry">
<meta name="citation_title" content="Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His">
<meta name="citation_author" content="Émilien N’Guessan">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Sandrine Bacot">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Florian Raes">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Julien Leenhardt">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author_institution" content="Department of Nuclear Medicine, Université Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France">
<meta name="citation_author" content="Thibault Guenard">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Laurent Dumas">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Catherine Ghezzi">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Daniel Fagret">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Charlotte Lombardi">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author_institution" content="Université Grenoble Alpes, CNRS U5525, TIMC-TREE, La Tronche, France">
<meta name="citation_author" content="Alexis Broisat">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_author" content="Mitra Ahmadi">
<meta name="citation_author_institution" content="Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="10">
<meta name="citation_firstpage" content="54">
<meta name="citation_doi" content="10.1186/s41181-025-00380-5">
<meta name="citation_pmid" content="40833585">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/pdf/41181_2025_Article_380.pdf">
<meta name="description" content="Mesothelin is a glycoprotein overexpressed in various cancers, with limited expression in healthy tissues. The single-domain antibody (sdAb, or nanobody) A1-His has previously successfully been validated in mice for the SPECT imaging of mesothelin ...">
<meta name="og:title" content="Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Mesothelin is a glycoprotein overexpressed in various cancers, with limited expression in healthy tissues. The single-domain antibody (sdAb, or nanobody) A1-His has previously successfully been validated in mice for the SPECT imaging of mesothelin ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12367608">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s41181-025-00380-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41181_2025_Article_380.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367608%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12367608/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12367608/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ejnmmiradchem.gif" alt="EJNMMI Radiopharmacy and Chemistry logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to EJNMMI Radiopharmacy and Chemistry" title="Link to EJNMMI Radiopharmacy and Chemistry" shape="default" href="http://ejnmmipharmchem.springeropen.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">EJNMMI Radiopharm Chem</button></div>. 2025 Aug 20;10:54. doi: <a href="https://doi.org/10.1186/s41181-025-00380-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s41181-025-00380-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22EJNMMI%20Radiopharm%20Chem%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22EJNMMI%20Radiopharm%20Chem%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22EJNMMI%20Radiopharm%20Chem%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22EJNMMI%20Radiopharm%20Chem%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Side by side comparison of NOTA and DOTA for conjugation efficiency, gallium-68 labeling, and in vivo biodistribution of anti-mesothelin sdAb A1-His</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22N%E2%80%99Guessan%20%C3%89%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Émilien N’Guessan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Émilien N’Guessan</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22N%E2%80%99Guessan%20%C3%89%22%5BAuthor%5D" class="usa-link"><span class="name western">Émilien N’Guessan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bacot%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Sandrine Bacot</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Sandrine Bacot</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bacot%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandrine Bacot</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raes%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Florian Raes</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Florian Raes</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Raes%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Florian Raes</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Leenhardt%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Julien Leenhardt</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Julien Leenhardt</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">
<sup>2</sup>Department of Nuclear Medicine, Université Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Leenhardt%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julien Leenhardt</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guenard%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Thibault Guenard</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Thibault Guenard</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guenard%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thibault Guenard</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dumas%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Laurent Dumas</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Laurent Dumas</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dumas%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laurent Dumas</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghezzi%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Catherine Ghezzi</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Catherine Ghezzi</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghezzi%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Catherine Ghezzi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fagret%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Daniel Fagret</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Daniel Fagret</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fagret%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel Fagret</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lombardi%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Charlotte Lombardi</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Charlotte Lombardi</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">
<sup>3</sup>Université Grenoble Alpes, CNRS U5525, TIMC-TREE, La Tronche, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lombardi%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charlotte Lombardi</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Broisat%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Alexis Broisat</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Alexis Broisat</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Broisat%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexis Broisat</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmadi%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Mitra Ahmadi</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Mitra Ahmadi</span></h3>
<div class="p">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ahmadi%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mitra Ahmadi</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Université Grenoble Alpes, INSERM U1039, LRB, Grenoble, France </div>
<div id="Aff2">
<sup>2</sup>Department of Nuclear Medicine, Université Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France </div>
<div id="Aff3">
<sup>3</sup>Université Grenoble Alpes, CNRS U5525, TIMC-TREE, La Tronche, France </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 12; Accepted 2025 Aug 6; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12367608  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40833585/" class="usa-link">40833585</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Mesothelin is a glycoprotein overexpressed in various cancers, with limited expression in healthy tissues. The single-domain antibody (sdAb, or nanobody) A1-His has previously successfully been validated in mice for the SPECT imaging of mesothelin positive tumors following radiolabeling with <sup>99m</sup>Tc. Our objective was to radiolabel this sdAb with <sup>68</sup>Ga for PET imaging, exhibiting superior sensitivity and resolution than SPECT in clinical practice. To this aim, it was conjugated to NOTA chelator that is commonly employed for <sup>68</sup>Ga labeling of antibody-derived tracers. In addition, the high affinity and specificity of A1-His sdAb position it as a promising candidate for theranostic applications. In anticipation of future radiolabeling with beta-emitting radionuclides, DOTA-conjugated A1-His was also evaluated. Given the high thermal stability of sdAbs, this DOTA-conjugated sdAb could potentially be implemented in future studies as a theranostic agent with beta-emitting radionuclides.</p></section><section id="sec2"><h3 class="pmc_sec_title">Results</h3>
<p id="Par2">A1-His was successfully conjugated to p-SCN-Bn-DOTA and p-SCN-Bn-NOTA under optimized conditions, achieving chelator-to-sdAb ratios of 1.8 and 1.3, respectively. NOTA-A1-His allowed rapid radiolabeling with <sup>68</sup>Ga at room temperature, achieving high radiochemical purity (&gt; 98%) within 5 min. Using DOTA, similar purity was obtained at 60 °C for 15 min. Both radiotracers demonstrated stability over 4 h in the radiolabeling medium and 2 h in human blood. However, some instability was observed in murine blood. Biodistribution and imaging studies in mice bearing mesothelin-expressing tumors showed specific tumor targeting for both tracers. Notably, [68Ga]Ga-DOTA-A1-His exhibited twofold lower kidney uptake compared to [68Ga]Ga-NOTA-A1-His, potentially enhancing imaging contrast and reducing renal radiation exposure. His-tag removal, further improves the biodistribution profile of the 2 tracers.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par3">Both p-SCN-Bn-DOTA and p-SCN-Bn-NOTA chelators can be effectively conjugated to the A1 sdAb and radiolabeled with <sup>68</sup>Ga, producing stable radiotracers with specific tumor-targeting capabilities. NOTA chelator offers advantages in rapid, room-temperature radiolabeling. However, DOTA would offer the advantage to be employed for theranostic approaches using β<sup>−</sup> emitters such as <sup>177</sup>Lu or <sup>161</sup>Tb. The lower kidney retention of DOTA-A1 also suggests that its dosimetry, a key factor in theranostic, would be more favorable.</p></section><section id="sec4"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s41181-025-00380-5.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> DOTA, NOTA, Gallium-68, Radiolabeling, Theranostics, sdAb, Nanobody, Radiopharmaceuticals, Mesothelin</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par30">Among the targets of cancer recently identified, the glycoprotein mesothelin has been proposed as a relevant target for tumor diagnosis and therapy (Faust et al. <a href="#CR8" class="usa-link" aria-describedby="CR8">2022</a>; Montemagno et al. <a href="#CR19" class="usa-link" aria-describedby="CR19">2020</a>). Our laboratory has developed and fully characterized the single domain antibody (sdAb) [99mTc]Tc-A1-His that targets both murine and human mesothelin. sdAbs, also known as VHHs or nanobodies, constitute the single variable domain of heavy-chain only antibodies found in camelids. They exhibit pharmacokinetics that are extremely favorable for the development of radiopharmaceuticals, including high affinity and specificity combined to a low molecular weight allowing high tumor uptake and fast blood clearance (Cong et al. <a href="#CR4" class="usa-link" aria-describedby="CR4">2024</a>). In vitro, A1-His binds to recombinant human mesothelin and to mesothelin expressing cells with nanomolar affinity. In vivo in mice bearing human pancreatic ductal adenocarcinoma (PDAC) or triple negative breast cancer (TNBC), mesothelin expression is observable using [99mTc]Tc-A1-His by Single Photon Emission Computed Tomography (SPECT) imaging, while no signal is identifiable in mesothelin negative tumors. The in vivo specificity of [99mTc]Tc-A1-His binding to mesothelin positive tumors was further confirmed by in vivo competition experiments (Montemagno et al. <a href="#CR20" class="usa-link" aria-describedby="CR20">2019</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">2018</a>). [99mTc]Tc-A1-His could therefore be translated to the clinic and be employed as a companion marker of the anti-mesothelin therapies currently undergoing clinical trials such as antibody–drug conjugates like DMOT4039A and BMS-986148 (Weekes et al. <a href="#CR27" class="usa-link" aria-describedby="CR27">2016</a>; Rottey et al. <a href="#CR26" class="usa-link" aria-describedby="CR26">2022</a>) or the numerous CART-T Cells currently under development (Zhai et al. <a href="#CR30" class="usa-link" aria-describedby="CR30">2023</a>). However, for the detection of tumor lesions in the clinical practice including metastasis, Positron Emission Tomography (PET) is usually considered as more relevant than SPECT, due to its higher sensitivity and resolution. Therefore, the goal of this study was to develop and characterize a PET version of A1-His labeled with <sup>68</sup>Ga.</p>
<p id="Par31">To this aim, a chelator with rapid kinetics seemed more suitable. However, while fast radiometal incorporation and low energetic barriers for radiometal-chelate complexation are beneficial, they can also result in fast demetallation and low energetic barriers for radiometal dissociation. Achieving the optimal PET agent requires a careful balance, necessitating the investigation of different chelator agents with distinct properties. Various chelators have been developed for trivalent isotopes, each of them offering different levels of thermodynamic and kinetic stability (Price and Orvig <a href="#CR24" class="usa-link" aria-describedby="CR24">2014</a>; Fersing et al. <a href="#CR9" class="usa-link" aria-describedby="CR9">2022</a>; Holik et al. <a href="#CR12" class="usa-link" aria-describedby="CR12">2022</a>; D’Onofrio et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2021</a>). Historically, acyclic DTPA-based ligands were considered as a standard in nuclear medicine for radiolabeling (Liu <a href="#CR16" class="usa-link" aria-describedby="CR16">2008</a>). However, advancements have led to the adoption of macrocyclic ligands such as DOTA, NOTA, and TRAP for <sup>68</sup>Ga, which provide enhanced stability. NOTA, a hexadentate chelator, is one of the oldest and most successful chelators for <sup>68</sup>Ga. It is widely regarded as the “gold standard” for Ga<sup>3+</sup> chelation, allowing rapid radiolabeling at room temperature and excellent in vivo stability. One straightforward solution with proteins is to perform random NOTA chelator coupling on side chain lysins. This has been previously performed by others in preclinical and clinical studies using antibodies or antibody fragments, including sdAb such as [68Ga]Ga-NOTA-anti-HER2 currently in phase II clinical trial (Gondry et al. <a href="#CR10" class="usa-link" aria-describedby="CR10">2024</a>).</p>
<p id="Par32">Another possible strategy is to use DOTA chelator. DOTA offers several advantages including an exceptional in vivo stability, a wide range of bifunctional DOTA derivatives and vector conjugates and, owing to its octadentate property, the possibility of complexing both imaging and therapeutic radiometals within the same framework. However, DOTA requires elevated temperatures for radiolabeling with most radiometals, which can be limiting for protein-based tracers such as antibodies or antibody fragments. Interestingly, sdAbs usually exhibit good thermal stability in comparison to other antibody formats. Therefore, DOTA was also considered as an option of PET imaging with <sup>68</sup>Ga in this study. One great advantage, for future studies, is the possibility of radiolabeling DOTA using beta- emitters, namely <sup>177</sup>Lu and <sup>161</sup>Tb, enabling theranostic evaluations and applications.</p>
<p id="Par33">Several studies have already been conducted to assess the differences between DOTA and NOTA chelators, highlighting the respective advantages and disadvantages of each when radiolabeling vectors with <sup>68</sup>Ga (Notni et al. <a href="#CR23" class="usa-link" aria-describedby="CR23">2012</a>; Ray Banerjee et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2016</a>). The objectives of this study were to identify the optimal parameters for NOTA and DOTA conjugation on A1-His and for their subsequent radiolabeling with <sup>68</sup>Ga. Then, their stability was evaluated in human and murine blood and their biodistribution, with or without His-tag, were investigated in mice bearing tumors using PET imaging and gamma-well counting.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">SdAbs production</h3>
<p id="Par34">A1-his was cloned into the pet15b expression vector, incorporating a hexahistidine tail. Transformation into SHuffle T7 Express Competent <em>E. coli</em> C3029J (New England Biolab) was performed. SdAbs expression was induced with 1 mM isopropyl-β-d-thiogalactoside (IPTG) at 37 °C overnight. Soluble extracts containing sdAbs were obtained through lysozyme and sonication, followed by a centrifugation step. Further purification involved immobilized metal affinity chromatography (IMAC) on Ni–NTA resin (Sigma-Aldrich) and gel filtration on Superdex 75 HR 16/60 (Cytiva) in Tris/NaCl pH 7.4. The affinity of A1-His for human mesothelin was evaluated using surface plasmonic resonance (SPR) as previously described (N’Guessan et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2025</a>). To produce sdAbs without the His-tag use in the biodistribution study, the proteins underwent TEV protease cleavage, as previously described (N’Guessan et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2025</a>).</p></section><section id="Sec4"><h3 class="pmc_sec_title">NOTA and DOTA conjugation to A1-His</h3>
<p id="Par35">The derivatives p-SCN-Bn-DOTA and p-SCN-Bn-NOTA were used for DOTA and NOTA coupling, respectively. To achieve the best conjugation rate of NOTA or DOTA to the sdAb, several conditions were tested, closely monitoring the influence of changes in the excess of chelator and the pH on the conjugation rate. A1-His, initially produced in Tris-NaCl pH 7.4, was buffer-exchanged into 0.5 M sodium carbonate buffer, pH 9.0 (sodium carbonate anhydrous–sodium hydrogen carbonate; Sigma-Aldrich) at the desired pH, using PD-10 size exclusion disposable columns (GE Healthcare). A twenty- or 50-fold molar excess of p-SCN-Bn-NOTA (2.5 mg/mL) or p-SCN-Bn-DOTA (3 mg/mL) was added to the A1-His solution (1.5 mg/mL) and the pH was adjusted to 8 or to 9. Each sample was then incubated for 3 h at 25 °C under stirring.</p>
<p id="Par36">Purifications were performed as described in our latest article (N’Guessan et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2025</a>). Briefly, after each conjugation reaction, the pH was adjusted to 7–7.5, and the solution was purified by size exclusion chromatography (SEC) using semi-preparative high-pressure liquid chromatography (HPLC; Shimadzu). The purified conjugates were then concentrated to 1 mg/mL using Amicon Ultra-15 filters (Ultracel® 3 K) for stability purpose. All samples were analyzed by MALDI-TOF MS using an Autoflex Speed mass spectrometer (Bruker Daltonics). After purification and analysis, each DOTA-conjugated sdAb sample was stored at − 80 °C. All samples were analyzed by Maldi-TOF–MS at various time points up to 2 years.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Gallium-68 labeling parameters</h3>
<p id="Par37">The factors affecting radiolabeling efficiency were explored by examining various parameters, including (a) reaction concentration, (b) pH of radiolabeling reaction and (c) incubation time, for both [68Ga]Ga-DOTA-A1-His and [68Ga]Ga-NOTA-A1-His. The mixture was heated to 60 °C (thermal stability of A1-His) in the presence of DOTA and maintained at room temperature (25 °C) with NOTA. The influence of all these parameters was evaluated by measuring the radiochemical purity (RCP) of each solution through radio-HPLC analysis. Each parameter was tested in triplicate.</p>
<p id="Par38">Radiochemical purity (RCP), was assessed using reversed-phase high-performance liquid chromatography (RP-HPLC). The analytical HPLC system (Shimadzu) was equipped with a radiodetector (Elysia-Raytest) and a UV detector (Shimadzu), utilizing a C4 reverse-phase column (Symmetry300™, 5 μm, 150 × 4.6 mm; Waters). The elution was performed with solvents A (0.1% trifluoroacetic acid (TFA) in water) and B (0.1% TFA in acetonitrile) at a flow rate of 1 mL/min under the following gradient conditions: 0–1 min, 5% B; 1–5 min, linear gradient from 5 to 90% B; 5–7 min, 90% B; 7–10 min, returning to initial conditions; and 10–12 min, 5% B. The radiochemical purity of each radiolabeled sdAb was determined by integrating the radioactivity peaks corresponding to the sdAb and any free radionuclide or impurities.</p>
<ol class="list" style="list-style-type:lower-alpha">
<li>
<p id="Par39">Reaction concentration</p>
<p>Either 50 µg or 100 µg of each conjugated A1-His (3.5 or 7 nmoles) were added to a mixture containing 1 M ammonium acetate buffer and Ga-68 eluate (145–222 MBq) (IRE ELiT®, Belgium). The pH of the mixture was adjusted to 3–4 and then incubated for 15 min with stirring at 300 rpm, at 60 °C for DOTA-A1-His and at room temperature for NOTA-A1-His.</p>
</li>
<li>
<p id="Par40">pH</p>
<p>100 µg of DOTA- or NOTA-conjugated A1-His (7 nmoles) in 1 M ammonium acetate were added to Ga-68 eluate (145–222 MBq). The reaction mixtures, adjusted to final pH values of 3, 4 or 5, were incubated for 15 min under stirring at 300 rpm/min, at room temperature for NOTA-A1-His and at 60 °C for DOTA-A1-His.</p>
</li>
<li>
<p id="Par41">Incubation time</p>
<p>100 µg of DOTA- or NOTA-conjugated A1-His (7 nmoles) in 1 M ammonium acetate were added to Ga-68 eluate (145–222 MBq). The reaction mixtures were adjusted to final pH values of 3 for DOTA- and 4 for NOTA. All samples were incubated for 15 min under stirring at 300 rpm/min, at room temperature for NOTA-A1-His and at 60 °C for DOTA-A1-His. A sample of each reaction medium was withdrawn at 5 min and 10 min, and analyzed by radio-HPLC.</p>
</li>
</ol>
<p id="Par42">The optimized labeling conditions described above were used to radiolabel the molecules for in vivo experiments. Radiolabeled sdAbs were purified by gel filtration using NAP-5 columns (Sephadex™ G-25 DNA Grade Gel, GE Healthcare) pre-equilibrated with PBS (Sigma-Aldrich, Cat. #D8662), and subsequently sterilized through 0.22 µm filters (Millex®, Millipore) prior to injection into animals.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Radiolabeling stability</h3>
<p id="Par43">The stability of [68Ga]Ga-DOTA-A1-His and [68Ga]Ga-NOTA-A1-His in the radiolabeled medium at room temperature was evaluated at 2 and 4 h by determining the RCP through radio-HPLC analysis, using the same conditions as immediately after radiolabeling. The experiments were carried out in triplicate. The stability was also evaluated in whole human and murine blood. Each radiotracer was at a concentration of 37 MBq/mL in blood and kept at 37 °C for 120 min. Samples of 150–200 µL were taken at 30, 60, and 120 min, and centrifuged at 4000 g for 2 min to separate plasma from blood cells. Plasma was then treated with 10% TCA to precipitate large proteins. After a second centrifugation at 13,000 g for 3 min, the RCP of supernatant (protein-free plasma fraction) was analyzed by radio-HPLC. Each experiment was conducted in triplicate.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Hydrophilicity</h3>
<p id="Par44">The partition coefficient (log P), an indicator of hydrophilicity, was determined for each radiolabeled compound by measuring its distribution between 1-octanol and phosphate-buffered saline (PBS). [68Ga]Ga-DOTA-A1-His or [68Ga]Ga-NOTA-A1-His was mixed with PBS and 1-octanol to achieve a 1:1 ratio between PBS and 1-octanol. After vortexing for 1 min, the vial was centrifuged for 3 min at 13,000 rpm to ensure complete separation of the layers. The 1-octanol phase and the buffer phase were then harvested and the radioactivity determined using a dose calibrator. This process was repeated with fresh phosphate buffer and 1-octanol. Log P was calculated as the logarithm of the ratio of radioactivity in the 1-octanol phase to that in the PBS buffer: Log P = log (total counts in 1-octanol / total counts in PBS buffer).</p></section><section id="Sec8"><h3 class="pmc_sec_title">Cell line and culture conditions</h3>
<p id="Par45">The HCC70 cell line, obtained from the American Type Culture Collection, was cultured in RPMI 1640 medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich) and 1% penicillin–streptomycin (Sigma-Aldrich). Cells were incubated at 37 °C with 5% CO₂.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Animal and tumor model</h3>
<p id="Par46">Approval for all procedures was obtained from the animal care and ethics committee of Grenoble Alpes University and the ad hoc French minister (APAFIS#19480–2019022616164184 v4). Mice had access to rodent chow and water ad libitum. They were on a 12 h light/dark cycle, temperature was maintained between 20 and 24 °C, and a relative humidity of 40–60%. A one-week acclimatization period was respected prior implantation.</p>
<p id="Par47">Twenty-seven female Athymic Nudes mice (Janvier, France) at 5–weeks of age were subcutaneously xenografted in the left posterior upper leg with HCC70 cells (3.5 × 10<sup>6</sup>) in 1:1 (v/v) PBS/Matrigel (Corning) mixture. Tumor growth was monitored using a caliper 2 to 3 times a week, allowing tumors to grow for 3–4 weeks to reach approximately 75–150 mm<sup>3</sup>.</p></section><section id="Sec10"><h3 class="pmc_sec_title">PET-CT imaging</h3>
<p id="Par48">PET/CT acquisitions were performed 1 h after intravenous injection via the tail vein of [68Ga]Ga-NOTA-A1-His, [68Ga]Ga-DOTA-A1-His, [68Ga]Ga-NOTA-A1 or [68Ga]Ga-DOTA-A1. Randomization ensured similar weights and tumor volumes between the two groups (Supplementary Table 1). An intravenous injection of 100 µl of Gelofusin® 4% was performed 1–2 min before the radiotracer injection to reduce the kidney retention. PET/CT acquisitions were performed using two dedicated system (nanoSPECT/CT and nanoPET/MRI; Mediso). Images were quantified after correction for decay and normalization to the injected dose using VivoQuant Software.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Biodistribution studies</h3>
<p id="Par49">Two hours after the injection and immediately after the image acquisition, the anesthetized mice were euthanized by cervical dislocation and tumors were harvested along with other organs. Tissues were weighed, and tracer activity was determined using a Wizard<sup>2</sup> γ-counter (Perkin Elmer). The results were corrected for decay, injected dose (ID), and organ weight and were expressed as %ID/g. Tumor-to-liver (T/L), tumor-to-kidney (T/K) and tumor-to-blood (T/B) activity ratios were computed<strong>.</strong></p></section><section id="Sec12"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par50">Mean values ± standard deviation (SD) were compared using nonparametric, two tailed and unpaired tests, i.e. the Mann–Whitney U test for comparison of two groups. P values of 0.05 or less were considered significant. Analysis were conducted with GraphPad 8.0.2 (Prism).</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec14"><h3 class="pmc_sec_title">NOTA and DOTA conjugation to A1-His</h3>
<p id="Par51">A1-His was successfully produced at a yield of 11.9 mg per liter of Lysogeny Broth culture medium. Similar conjugation rates were observed with NOTA and DOTA using a 20-fold molar excess of chelator at pH 8. Under these conditions, most sdAb remained unconjugated (66% for NOTA and 65% for DOTA), while mono-conjugated sdAb represented 32% for both chelators and bi-conjugated 2 and 3%, respectively. Consequently, the mean conjugation rate was of 0.4 for both chelators. Increasing the excess of chelator to 50 enhanced the conjugation rate to 0.7 for NOTA and 1.1 for DOTA. Similarly, increasing the pH to 9 enhanced the conjugation rate to 0.8 for NOTA and 1.3 for DOTA. These two effects were found to be additive, so that a 50-fold excess of chelator at pH 9 resulted in conjugation rates of 1.3 for NOTA and 1.8 for DOTA (Fig. <a href="#Fig1" class="usa-link">1</a>). The 50-fold excess and pH9 were selected as the most potent conditions. Upon storage at − 80 °C at 1 mg/mL, the conjugation remained stable for two years.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367608_41181_2025_380_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/ca5d896e4f57/41181_2025_380_Fig1_HTML.jpg" loading="lazy" id="MO1" height="476" width="709" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Evaluation of the effect of molar-excess of chelator per sdAb and pH on the conjugation rate</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">Gallium-68 labeling</h3>
<p id="Par52">Prior to all radiolabeling, the thermal stability of A1-His was assessed using Circular Dichroism analysis, identifying 60 °C as the maximum temperature at which no changes in the secondary structure of A1-His were observed (N’Guessan et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2025</a>). This indicates that DOTA radiolabeling can only be performed at temperatures below 60 °C. In contrast, NOTA did not require heating, so all experiments with NOTA were conducted at room temperature (25 °C).</p>
<ol class="list" style="list-style-type:lower-alpha">
<li>
<p id="Par53">Reaction concentration</p>
<p>The effect of A1-His concentration on the radiochemical purity (RCP) of the reactions for both [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His was investigated (Fig. <a href="#Fig2" class="usa-link">2</a>A). The reactions were carried out at two different concentrations of A1-His: 50 µg/mL and 100 µg/mL. Radiochromatograms are available as supplemental data (Supplementary Fig. 1).</p>
<p>For both chelators, the RCP was &lt; 95% at the concentration of 50 µg/mL (85 ± 1% and 87 ± 4% for NOTA and DOTA, respectively), and the concentration of 100 µg/mL resulted in a RCP &gt; 95% (98 ± 1% and 96 ± 3% for NOTA and DOTA, respectively). The concentration of 100 µg/mL was therefore selected for further studies.</p>
</li>
<li>
<p id="Par54">pH</p>
<p>The radiolabeling was carried out at pH 3, 4, and 5 (Fig. <a href="#Fig2" class="usa-link">2</a>B). For [68Ga]Ga-NOTA-A1-His, the highest RCP was observed at pH 4 where it reached 98 ± 1%. For [68Ga]Ga-DOTA-A1-His, the highest RCP was observed at pH 3. At this pH, the RCP was of 96 ± 2% and was significantly higher than that of [68Ga]Ga-NOTA-A1-His (<em>p</em> &lt; 0.001).</p>
</li>
<li>
<p id="Par55">Incubation time</p>
<p>The effect of incubation time on the radiochemical purity (RCP) of the reactions for both NOTA and DOTA was evaluated at three different incubation times: 5, 10, and 15 min (Fig. <a href="#Fig3" class="usa-link">3</a>). [68Ga]Ga-NOTA-A1-His RCP was of 95 ± 2%, 97 ± 4% and 99 ± 1% at 5, 10 and 15 min, respectively. In comparison, the initial [68Ga]Ga-DOTA-A1-His RCP, determined at 5 min, was of 18 ± 19%. It then increased overtime and was &gt; 95% at 15 min (96 ± 3%).</p>
</li>
</ol>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367608_41181_2025_380_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/7bc2314699c0/41181_2025_380_Fig2_HTML.jpg" loading="lazy" id="MO2" height="354" width="709" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Radiochemical purity of [<sup>68</sup>Ga]Ga-NOTA-A1-His and [<sup>68</sup>Ga]Ga-DOTA-A1-His immediately after radiolabeling as a function of A1-His concentration (<strong>A</strong>) and pH (<strong>B</strong>). *<em>P</em> &lt; 0.05 vs. NOTA and ***<em>P</em> &lt; 0.001 <em>vs</em> NOTA</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367608_41181_2025_380_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/e4431cbc065d/41181_2025_380_Fig3_HTML.jpg" loading="lazy" id="MO3" height="487" width="709" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Radiochemical purity of [<sup>68</sup>Ga]Ga-NOTA-A1-His and [<sup>68</sup>Ga]Ga-DOTA-A1-His evaluated as a function of incubation time. ***<em>P</em> &lt; 0.001 vs NOTA</p></figcaption></figure></section><section id="Sec16"><h3 class="pmc_sec_title">Radiolabeling stability and blood distribution</h3>
<p id="Par56">After identifying the best parameters for the radiolabeling, the stabilities were studied in the radiolabeling medium as well as in murine and human blood. In the radiolabeling medium, at 4 h the RCP of [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His was 98 ± 1 and 96 ± 2%, respectively. Stability in whole blood was evaluated following blood cell and large proteins removal. We took advantage of this method to also evaluate the distribution of the sdAbs between the different fractions. In vivo, this repartition could impact the availability of the sdAb for their target. Due to the very fast blood clearance of sdAbs, we focused on the early time points of 0 and 30 min when their binding occurs (Fig. <a href="#Fig4" class="usa-link">4</a>). Blood distribution at later time point is available as supplemental data (Supplementary Fig. 2). The majority of [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His were found to be located in the plasma, either in the protein or the free fraction, both in murine and human blood. The highest activity on the blood cell fraction was observed for [68Ga]Ga-DOTA-A1-His in human blood where it was of 40 ± 5% and 37 ± 7% at 0 and 30 min, respectively (<em>versus</em> 26 ± 4 and 19 ± 4% at similar time points for [68Ga]Ga-NOTA-A1-His). In murine blood, [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1 distributions were found to be comparable.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367608_41181_2025_380_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/fb657f1e8068/41181_2025_380_Fig4_HTML.jpg" loading="lazy" id="MO4" height="364" width="709" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>[<sup>68</sup>Ga]Ga-NOTA-A1-His and [<sup>68</sup>Ga]Ga-DOTA-A1-His distribution determined in vitro in whole human and murine blood</p></figcaption></figure><p id="Par57">The stability was then evaluated in the protein-free plasma fraction (Fig. <a href="#Fig5" class="usa-link">5</a>). Elevate stabilities were observed for [68Ga]Ga-NOTA-A1-His in murine and human blood, with RCP of 91 ± 3 and 89 ± 2% at 120 min, respectively. A significant reduction in the stability was found for [68Ga]Ga-DOTA-A1 in murine blood, with RCP decreased from 95 ± 1 to 81 ± 10 at 30 min, and 65 ± 3% at 120 min. This was however not observed in human blood where the stability was similar to that of [68Ga]Ga-NOTA-A1 and was still of 89 ± 4% at 120 min.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/acad3bd6c373/41181_2025_380_Fig5_HTML.jpg" loading="lazy" id="MO5" height="596" width="629" alt="Fig. 5"></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Stability of [<sup>68</sup>Ga]Ga-NOTA-A1-His and [<sup>68</sup>Ga]Ga-DOTA-A1-His in human and mouse blood. *<em>vs</em> human blood; # <em>vs</em> [<sup>68</sup>Ga]Ga-NOTA-A1-His and †<em>vs</em> [<sup>68</sup>Ga]Ga-NOTA-A1-His</p></figcaption></figure></section><section id="Sec17"><h3 class="pmc_sec_title">Hydrophilicity</h3>
<p id="Par58">Hydrophilicity’s of the two radiotracers were compared using octanol-PBS partition coefficient (logP). The LogP of [68Ga]Ga-DOTA-A1-His was determined to be -1.92 ± 0.23, while it was of − 2.24 ± 0.32 for [68Ga]Ga-NOTA-A1-His, indicating that both are hydrophilic.</p></section><section id="Sec18"><h3 class="pmc_sec_title">In vivo biodistribution</h3>
<p id="Par59">By PET/CT imaging, HCC70 tumors were visible using both [68Ga]Ga-DOTA-A1-His and [68Ga]Ga-NOTA-A1-His. The signal was low in the other organs, to the exception of the kidneys and bladder. Interestingly, the kidney retention of [68Ga]Ga-NOTA-A1-His appeared to be higher than that of [68Ga]Ga-DOTA-A1-His (Fig. <a href="#Fig6" class="usa-link">6</a>A–B). The quantification of the biodistribution by gamma well counting was in accordance with these observations (Fig. <a href="#Fig6" class="usa-link">6</a>C–E). Indeed, the kidney retention of [68Ga]Ga-DOTA-A1-His was found to be 40% lower than [68Ga]Ga-NOTA-A1-His (29.10 ± 2.24 <em>vs</em> 50.42 ± 8.02%ID/g, <em>p</em> &lt; 0.01). The two sdAbs without His-tag showed lower kidney retention as expected. Interestingly, the kidney retention of [68Ga]Ga-DOTA-A1 was also found to be 30% lower compared to [68Ga]Ga-NOTA-A1 (11.44 ± 1.16 <em>vs</em> 15.48 ± 1.81%ID/g, <em>p</em> &lt; 0.01). In the other investigated organs, no major differences were observed between the two radiotracers (Supplementary Tables 2 and 3) and the activities were &lt; 1%ID/g to the exception of the tumor where similar uptakes were found for both radiotracers. As a consequence, the tumor to kidney ratios were significantly higher using DOTA (<em>p</em> &lt; 0.01 <em>vs</em> NOTA).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367608_41181_2025_380_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a55b/12367608/0270ad16185c/41181_2025_380_Fig6_HTML.jpg" loading="lazy" id="MO6" height="979" width="709" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Biodistribution of [<sup>68</sup>Ga]Ga-NOTA-A1-His, [<sup>68</sup>Ga]Ga-DOTA-A1-His, [<sup>68</sup>Ga]Ga-DOTA-A1 and [<sup>68</sup>Ga]Ga-DOTA-A1 in Athymic Nude mice bearing HCC70 xenografts (n = 6–7) determined by PET/CT imaging (<strong>A</strong>–<strong>B</strong>) and ex vivo gamma well counting (<strong>C</strong>–<strong>E</strong>). <strong>A–B:</strong> Representative maximum intensity projection of PET/CT images acquired at 1 h after intravenous injection, using whole body field of view and a 0–5%ID/cm<sup>3</sup> min–max (<strong>A</strong>) or a field of view focused on the kidney and a 0–50%ID/cm<sup>3</sup> min–max (<strong>B</strong>). Biodistribution was evaluated by gamma well counting in major organs and tumor (<strong>C</strong>). Tumor-to-blood, tumor-to-liver, tumor-to-muscle and tumor-to-/kidney ratios were also determined (<strong>D</strong>–<strong>E</strong>). <strong>*</strong>: sdAbs [<sup>68</sup>Ga]Ga-DOTA labeled, significantly different from their NOTA version (*<em>p</em> &lt; 0.05; **<em>p</em> &lt; 0.01). <sup><strong>#</strong></sup>: sdAbs without tag-his, significantly different from their tag-his version (<sup><strong>##</strong></sup><em>p</em> &lt; 0.01; <sup><strong>###</strong></sup><em>p</em> &lt; 0.001)</p></figcaption></figure></section></section><section id="Sec19"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par60">Both bifunctional chelating agents, NOTA and DOTA, are widely used for complexing with Gallium, each of them owning advantages and disadvantages depending on the application. NOTA forms a highly stable complex with Ga-68 (log stability constant of 30.98) (Xavier and Vaneycken <a href="#CR28" class="usa-link" aria-describedby="CR28">2013</a>) and remains stable in the presence of serum cations such as Ca<sup>2+</sup>, Mg<sup>2+</sup>, and Zn<sup>2+</sup>. The complexation occurs with rapid kinetics, often at room temperature, making it highly suitable for labeling thermosensitive molecules like proteins. However, its structure with six coordination bonds limits its use in theranostics with radioisotopes such as Lu-177, Tb-161, or Ac-225. On the other hand, DOTA is a widely used chelating agent for a broad range of radioisotopes and is the chelating agent of choice for theranostic studies. Its drawback remains its slow kinetics, which restricts its use with thermosensitive molecules.</p>
<p id="Par61">In this study we explored whether using these different chelators could affect the in vivo efficiency of our A1-His radioligand. To achieve this, we first established all the parameters for the conjugation and radiolabeling.</p>
<p id="Par62">Several studies have already been conducted to compare the effects of different chelators (Krutzek et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2024</a>) or more precisely NOTA and DOTA chelators in in vivo studies to complex <sup>68</sup> Ga (Dam et al. <a href="#CR7" class="usa-link" aria-describedby="CR7">2022</a>; Guleria et al. <a href="#CR11" class="usa-link" aria-describedby="CR11">2018</a>; Xia et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2020</a>), <sup>64</sup>Cu (Lee et al. <a href="#CR15" class="usa-link" aria-describedby="CR15">2023</a>; Zhang et al. <a href="#CR31" class="usa-link" aria-describedby="CR31">2011</a>) or <sup>55</sup>Co (Mitran et al. <a href="#CR17" class="usa-link" aria-describedby="CR17">2019</a>). The sdAb A1-His appears to be a good candidate to compare NOTA and DOTA using bispecific chelators and coupling on lysine residues. Indeed, the thermal stability of sdAbs is elevated in comparison to other antibody fragments (Nanobodies <a href="#CR21" class="usa-link" aria-describedby="CR21">2013</a>; Bekker et al. <a href="#CR3" class="usa-link" aria-describedby="CR3">2019</a>). In addition, one key challenge when conjugating a sdAb on lysine residues is avoiding potential interference with its antigen-binding specificity (Bannas et al. <a href="#CR1" class="usa-link" aria-describedby="CR1">2017</a>), but there are no lysine residues in the complementarity-determining regions (CDRs) of A1-His (N’Guessan et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2025</a>).</p>
<p id="Par63">In this study, given the number of lysines present per nanobody (i.e. 4), our initial goal for conjugation was to establish conditions that would first decrease unconjugated sdAb, thereby increasing the molar activity during Ga-labeling, and second, increase the conjugation rate of the chelator per molecule. By applying the same conditions to both chelators, the initial rate of 0.4 per molecule was identical. Subsequently, by adjusting the excess of chelator and the pH, the first objective was achieved for both, with negligible levels of unconjugated sdAb under using a fifty-molar excess of chelator at pH 9. After conjugation, the sdAb exhibited elevated stability when concentrated at 1 mg/mL and stored at − 80 °C.</p>
<p id="Par64">Optimization of radiolabeling conditions was then performed. The evaluated parameters included concentration, pH, incubation time, and molar activity. The optimal radiolabeling parameters for [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His differed regarding the pH, reflecting the structural and chemical differences between these two chelators. Studies have shown that NOTA achieves optimal radiolabeling yields at a slightly acidic pH of 4, while DOTA requires more acidic conditions, with a pH of 3, to achieve maximum radiochemical purity (Jeong and Kim <a href="#CR13" class="usa-link" aria-describedby="CR13">2009</a>). This difference is attributed to the more rigid, macrocyclic structure of DOTA, which necessitates a lower pH to facilitate <sup>68</sup>Ga complexation. In contrast, NOTA's slightly higher optimal pH for radiolabeling (around 4) suggests that its more flexible structure allows <sup>68</sup>Ga binding under milder acidic conditions. Such distinctions underscore the need to carefully adjust pH for each chelator to maximize labeling efficiency and ensure high radiochemical purity, especially in the context of clinical applications where consistency and stability of radiotracers are critical. Consequently, selecting the appropriate pH, based on chelator properties, is essential for optimizing <sup>68</sup>Ga labeling, with implications for both in vitro and in vivo performance of the resulting radiotracers.</p>
<p id="Par65">NOTA achieves high purity at RT rapidly and consistently within 5 min, while DOTA requires a longer incubation time of 15 min and heating at 60 °C to reach comparable levels of purity. Although the NOTA‑conjugated samples looked more homogeneous across incubation times, the differences were not statistically significant. This apparent uniformity still favors reproducibility. By contrast, DOTA labeling, normally performed above 80 °C, was carried out at 60 °C to protect the sdAb. The incubation time was therefore prolonged relative to standard protocols, which may have contributed to the greater variability observed.</p>
<p id="Par66">In the radiolabeling medium [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His demonstrated good stability up to 4 h post-incubation. In vitro in human and murine blood, the majority of [68Ga]Ga-DOTA-A1-His and [68Ga]Ga-NOTA-A1-His was found in the plasma fractions. However, [68Ga]Ga-DOTA-A1-His activity located within the blood cells in human blood was higher than that of [68Ga]Ga-NOTA-A1-His, suggesting that the bioavailability of the two radiotracers might differ following intravenous injection. Furthermore, [68Ga]Ga-DOTA-A1-His stability in murine blood was found to be lower than that of [68Ga]Ga-NOTA-A1-His or than that observed in human blood, as early as at 30 min. Those results are similar to those of the literature, such as in the comparative evaluation of [68Ga]Ga-labeled TATEs (Xia et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2020</a>). This could impact its biodistribution and lower the amount of specific binding to its target. However, no such difference in tumor uptake was observed in vivo in mice bearing HCC70 tumors. This might be attributed to the fact that the blood kinetic of sdAbs is rapid and that most of the specific binding occurs in the first minutes when the RCP is elevated.</p>
<p id="Par67">PET is a powerful non-invasive imaging modality that offers whole-body visualization, playing a critical role in oncology. Due to its elevated sensitivity and resolution, PET imaging is usually favored to SPECT when developing new radiopharmaceuticals to phenotype the tumors, monitor the disease progression including metastasis, and evaluate the efficacy of treatments (Crișan et al. <a href="#CR5" class="usa-link" aria-describedby="CR5">2022</a>). In vivo in mice bearing HCC70 tumors, the biodistribution profiles of [68Ga]Ga-NOTA-A1-His and [68Ga]Ga-DOTA-A1-His were remarkably similar, demonstrating that the choice of the chelator does not affect the specific targeting of mesothelin-expressing tumors. Moreover, low bone activity confirmed the stability of the radiolabeling. However, a significant difference was observed in the renal uptake. The DOTA-conjugated sdAbs exhibited a significantly lower kidney uptake compared to the NOTA-conjugated. This reduction in renal accumulation is advantageous for imaging applications, as it enhances tumor-to-kidney contrast and even more critical for therapeutic application as it reduces the radiation exposure to the kidneys, which is a critical consideration in radiopharmaceutical development. This lower renal uptake may be attributed to the type and number of chelators attached to the sdAb molecule. During the conjugation studies, the DOTA chelator achieved a higher chelator-to-sdAb ratio (1.8) compared to NOTA (1.3). Previous research has suggested that the degree of chelator conjugation can influence the pharmacokinetics and biodistribution of sdAb-based radiotracers (Baudhuin et al. <a href="#CR2" class="usa-link" aria-describedby="CR2">2021</a>). A higher chelator density might affect the overall charge, hydrophilicity, and protein binding properties of the sdAb, potentially reducing renal reabsorption and facilitating faster renal clearance. Moreover, the net charges of the conjugates could also have an impact on their in vivo kinetics and further studies will be conducted to investigate this parameter.</p>
<p id="Par68">From a clinical translation perspective, the use of DOTA as a chelator presents several advantages. DOTA is capable of forming stable complexes not only with Gallium-68 for PET imaging but also with therapeutic radionuclides such as Lutetium-177 and Terbium-161. This versatility allows for the development of a single sdAb-based molecule that can be utilized for both diagnostic imaging and radionuclide therapy, simplifying the production process, regulatory and toxicity evaluations. The ability to use one molecule for theranostic applications aligns with the growing interest in personalized medicine, where treatments are tailored to the specific characteristics of an individual's disease. However, the practical aspects of radiolabeling also need to be considered. The NOTA chelator offers the significant advantage of rapid and efficient radiolabeling with <sup>68</sup>Ga at room temperature, which is highly beneficial for clinical routine. In contrast, DOTA requires higher temperatures (up to 60 °C in our study) and incubation time a little longer than NOTA to achieve optimal radiochemical purity. This duration is however compatible with routine clinical practice, and is much more rapid than the one previously required using tricarbonyl for <sup>99m</sup>Tc labeling (90 min, at 60 °C) (Montemagno et al. <a href="#CR18" class="usa-link" aria-describedby="CR18">2018</a>).</p></section><section id="Sec20"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par69">This study demonstrated that both DOTA and NOTA chelators can be effectively conjugated to the anti-mesothelin sdAb A1-His and radiolabeled with gallium-68. While [68Ga]Ga-NOTA-A1-His allows rapid radiolabeling at room temperature, facilitating clinical routines, [68Ga]Ga-DOTA-A1-His showed significantly lower kidney uptake and have the ability to chelate therapeutic radionuclides like lutetium-177. Moreover, his-tag removal efficiently reduced kidney retention. The sdAb [68Ga]Ga-DOTA-A1 is therefore a suitable candidate for theranostic applications.</p></section><section id="Sec21"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12367608/bin/41181_2025_380_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (150.5KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Sabine Chierici from The Institut de Chimie Moléculaire de Grenoble (ICMG) is acknowledged for providing facilities for mass spectrometry (UAR2607).</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>%ID/g</dt>
<dd><p id="Par4">Percent of injected dose per gram</p></dd>
<dt>
<sup>177</sup>Lu</dt>
<dd><p id="Par5">Lutétium-177</p></dd>
<dt>
<sup>68</sup>Ga</dt>
<dd><p id="Par6">Gallium-68</p></dd>
<dt>
<sup>161</sup>Tb</dt>
<dd><p id="Par7">Terbium-161</p></dd>
<dt>A1-His</dt>
<dd><p id="Par8">Anti-mesothelin sdAb A1 with a hexahistidine tag</p></dd>
<dt>CT</dt>
<dd><p id="Par9">Computed tomography</p></dd>
<dt>DOTA</dt>
<dd><p id="Par10">1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</p></dd>
<dt>HER2</dt>
<dd><p id="Par11">Human epidermal growth factor receptor 2</p></dd>
<dt>HPLC</dt>
<dd><p id="Par12">High-pressure liquid chromatography</p></dd>
<dt>IMAC</dt>
<dd><p id="Par13">Immobilized metal affinity chromatography</p></dd>
<dt>MALDI-TOF</dt>
<dd><p id="Par14">Matrix assisted laser desorption ionization Time of flight</p></dd>
<dt>MMR</dt>
<dd><p id="Par15">Macrophage mannose receptor</p></dd>
<dt>MSLN</dt>
<dd><p id="Par16">Mesothelin</p></dd>
<dt>NOTA</dt>
<dd><p id="Par17">2,2′,2″-(1,4,7-triazacyclononane-1,4,7-triyl)triacetic acid</p></dd>
<dt>p-SCN-Bn-DOTA</dt>
<dd><p id="Par18">p-Isothiocyanatobenzyl derivative of DOTA</p></dd>
<dt>p-SCN-Bn-NOTA</dt>
<dd><p id="Par19">p-Isothiocyanatobenzyl derivative of NOTA</p></dd>
<dt>PBS</dt>
<dd><p id="Par20">Phosphate buffer saline</p></dd>
<dt>PET</dt>
<dd><p id="Par21">Positron emission tomography</p></dd>
<dt>RCP</dt>
<dd><p id="Par22">Radiochemical purities</p></dd>
<dt>SD</dt>
<dd><p id="Par23">Standard deviation</p></dd>
<dt>sdAb</dt>
<dd><p id="Par24">Single domain antibody</p></dd>
<dt>SEC</dt>
<dd><p id="Par25">Size exclusion chromatography</p></dd>
<dt>SPECT</dt>
<dd><p id="Par26">Single photon emission computed tomography</p></dd>
<dt>SPR</dt>
<dd><p id="Par27">Surface plasmon resonance</p></dd>
<dt>TNBC</dt>
<dd><p id="Par28">Triple negative breast cancer</p></dd>
<dt>VHH</dt>
<dd><p id="Par29">Variable regions of the heavy chain of heavy-chain-only antibodies</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conception and design: CG, DF, AB, MA. Acquisition of data: ENG (protein engineering, in vitro evaluation, cells cultures, animal model, in vivo evaluation), SB (Radiochemistry), FR (cells cultures, in vivo evaluation), TG (Radiochemistry), LD (protein engineering, in vivo evaluation), CL (protein engineering), AB (in vitro and in vivo evaluation), MA (radiochemistry). Analysis and interpretation of data: ENG, SB, FR, TG, JL (radiochemistry), CL, AB, MA. Drafting of the manuscript: ENG, SB, FR, CL, AB, MA. Critical revision of the manuscript: JL, LD, CG, DF. Final approval: all. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: all.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the Institut National du Cancer (INCa PLBIO 2021-231), Fondation ARC pour la recherche sur le cancer and La Ligue Contre le Cancer (LNCC—Comité de l’Isère—2023). This work was performed on a platform of France Life Imaging network partly funded by the grant “ANR-11-INBS-0006”.</p></section><section id="notes3"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethical approval and consent to participate:</h3>
<p id="Par70">All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted (APAFIS#19480-2019022616164184 v4).</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par71">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interest</h3>
<p id="Par72">AB, CG and DF are inventor on the patent EP3676296A1 on A1 sdAb.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ol class="ref-list font-sm">
<li id="CR1">
<cite>Bannas P, Hambach J, Koch-Nolte F. Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics. Front Immunol. 2017;8:1603.
</cite> [<a href="https://doi.org/10.3389/fimmu.2017.01603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5702627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29213270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bannas%20P,%20Hambach%20J,%20Koch-Nolte%20F.%20Nanobodies%20and%20nanobody-based%20human%20heavy%20chain%20antibodies%20as%20antitumor%20therapeutics.%20Front%20Immunol.%202017;8:1603." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<cite>Baudhuin H, Puttemans J, Hanssens H, Vanwolleghem P, Hernot S, Raes G, et al. Decorating sdAbs with chelators: effect of conjugation on biodistribution and functionality. Pharmaceuticals. 2021;14(5):407.
</cite> [<a href="https://doi.org/10.3390/ph14050407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8146233/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33923088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baudhuin%20H,%20Puttemans%20J,%20Hanssens%20H,%20Vanwolleghem%20P,%20Hernot%20S,%20Raes%20G,%20et%20al.%20Decorating%20sdAbs%20with%20chelators:%20effect%20of%20conjugation%20on%20biodistribution%20and%20functionality.%20Pharmaceuticals.%202021;14(5):407." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<cite>Bekker G, Ma B, Kamiya N. Thermal stability of single-domain antibodies estimated by molecular dynamics simulations. Protein Sci. 2019;28(2):429–38.
</cite> [<a href="https://doi.org/10.1002/pro.3546" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6319760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30394618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bekker%20G,%20Ma%20B,%20Kamiya%20N.%20Thermal%20stability%20of%20single-domain%20antibodies%20estimated%20by%20molecular%20dynamics%20simulations.%20Protein%20Sci.%202019;28(2):429%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<cite>Cong Y, Devoogdt N, Lambin P, Dubois LJ, Yaromina A. Promising diagnostic and therapeutic approaches based on VHHs for cancer management. Cancers. 2024;16(2):371.
</cite> [<a href="https://doi.org/10.3390/cancers16020371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10814765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38254860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cong%20Y,%20Devoogdt%20N,%20Lambin%20P,%20Dubois%20LJ,%20Yaromina%20A.%20Promising%20diagnostic%20and%20therapeutic%20approaches%20based%20on%20VHHs%20for%20cancer%20management.%20Cancers.%202024;16(2):371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<cite>Crișan G, Moldovean-Cioroianu NS, Timaru DG, Andrieș G, Căinap C, Chiș V. Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade. IJMS. 2022;23(9): 5023.
</cite> [<a href="https://doi.org/10.3390/ijms23095023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9103893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35563414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cri%C8%99an%20G,%20Moldovean-Cioroianu%20NS,%20Timaru%20DG,%20Andrie%C8%99%20G,%20C%C4%83inap%20C,%20Chi%C8%99%20V.%20Radiopharmaceuticals%20for%20PET%20and%20SPECT%20imaging:%20a%20literature%20review%20over%20the%20last%20decade.%20IJMS.%202022;23(9):%205023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<cite>D’Onofrio A, Silva F, Gano L, Karczmarczyk U, Mikołajczak R, Garnuszek P, et al. Clickable radiocomplexes with trivalent radiometals for cancer theranostics: in vitro and in vivo studies. Front Med. 2021;8:647379.</cite> [<a href="https://doi.org/10.3389/fmed.2021.647379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8225959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34179038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%E2%80%99Onofrio%20A,%20Silva%20F,%20Gano%20L,%20Karczmarczyk%20U,%20Miko%C5%82ajczak%20R,%20Garnuszek%20P,%20et%20al.%20Clickable%20radiocomplexes%20with%20trivalent%20radiometals%20for%20cancer%20theranostics:%20in%20vitro%20and%20in%20vivo%20studies.%20Front%20Med.%202021;8:647379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<cite>Dam JH, Langkjær N, Baun C, Olsen BB, Nielsen AY, Thisgaard H. Preparation and evaluation of [18F]AlF-NOTA-NOC for PET imaging of neuroendocrine tumors: comparison to [68Ga]Ga-DOTA/NOTA-NOC. Molecules. 2022;27(20):6818.
</cite> [<a href="https://doi.org/10.3390/molecules27206818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9609173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36296411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dam%20JH,%20Langkj%C3%A6r%20N,%20Baun%20C,%20Olsen%20BB,%20Nielsen%20AY,%20Thisgaard%20H.%20Preparation%20and%20evaluation%20of%20%5B18F%5DAlF-NOTA-NOC%20for%20PET%20imaging%20of%20neuroendocrine%20tumors:%20comparison%20to%20%5B68Ga%5DGa-DOTA/NOTA-NOC.%20Molecules.%202022;27(20):6818." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<cite>Faust JR, Hamill D, Kolb EA, Gopalakrishnapillai A, Barwe SP. Mesothelin: an immunotherapeutic target beyond solid tumors. Cancers. 2022;14(6):1550.
</cite> [<a href="https://doi.org/10.3390/cancers14061550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8946840/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35326701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Faust%20JR,%20Hamill%20D,%20Kolb%20EA,%20Gopalakrishnapillai%20A,%20Barwe%20SP.%20Mesothelin:%20an%20immunotherapeutic%20target%20beyond%20solid%20tumors.%20Cancers.%202022;14(6):1550." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<cite>Fersing C, Masurier N, Rubira L, Deshayes E, Lisowski V. AAZTA-derived chelators for the design of innovative radiopharmaceuticals with theranostic applications. Pharmaceuticals. 16 févr 2022;15(2):234.</cite> [<a href="https://doi.org/10.3390/ph15020234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8879111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35215346/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<cite>Gondry O, Caveliers V, Xavier C, Raes L, Vanhoeij M, Verfaillie G, et al. Phase II trial assessing the repeatability and tumor uptake of [68Ga]Ga-HER2 single-domain antibody PET/CT in patients with breast carcinoma. J Nucl Med. 2024;65(2):178–84.
</cite> [<a href="https://doi.org/10.2967/jnumed.123.266254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10858381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38302159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gondry%20O,%20Caveliers%20V,%20Xavier%20C,%20Raes%20L,%20Vanhoeij%20M,%20Verfaillie%20G,%20et%20al.%20Phase%20II%20trial%20assessing%20the%20repeatability%20and%20tumor%20uptake%20of%20%5B68Ga%5DGa-HER2%20single-domain%20antibody%20PET/CT%20in%20patients%20with%20breast%20carcinoma.%20J%20Nucl%20Med.%202024;65(2):178%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<cite>Guleria M, Das T, Amirdhanayagam J, Sarma HD, Dash A. Comparative evaluation of using NOTA and DOTA derivatives as bifunctional chelating agents in the preparation of <sup>68</sup>Ga-labeled porphyrin: impact on pharmacokinetics and tumor uptake in a mouse model. Cancer Biother Radiopharm Févr. 2018;33(1):8–16.</cite> [<a href="https://doi.org/10.1089/cbr.2017.2337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29373046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guleria%20M,%20Das%20T,%20Amirdhanayagam%20J,%20Sarma%20HD,%20Dash%20A.%20Comparative%20evaluation%20of%20using%20NOTA%20and%20DOTA%20derivatives%20as%20bifunctional%20chelating%20agents%20in%20the%20preparation%20of%2068Ga-labeled%20porphyrin:%20impact%20on%20pharmacokinetics%20and%20tumor%20uptake%20in%20a%20mouse%20model.%20Cancer%20Biother%20Radiopharm%20F%C3%A9vr.%202018;33(1):8%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<cite>Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The chemical scaffold of theranostic radiopharmaceuticals: radionuclide, bifunctional chelator, and pharmacokinetics modifying linker. Molecules. 2022;27(10):3062.
</cite> [<a href="https://doi.org/10.3390/molecules27103062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9143622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35630536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Holik%20HA,%20Ibrahim%20FM,%20Elaine%20AA,%20Putra%20BD,%20Achmad%20A,%20Kartamihardja%20AHS.%20The%20chemical%20scaffold%20of%20theranostic%20radiopharmaceuticals:%20radionuclide,%20bifunctional%20chelator,%20and%20pharmacokinetics%20modifying%20linker.%20Molecules.%202022;27(10):3062." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13"><cite>Jeong JM, Kim. Radiolabeling of NOTA and DOTA with positron emitting 68Ga and investigation of in vitro propertiespdf. Nuclear Med Mol Imag. 2009;43(4):330–6.</cite></li>
<li id="CR14">
<cite>Krutzek F, Donat CK, Stadlbauer S. Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands. EJNMMI radiopharm chem. 2024;9(1):14.
</cite> [<a href="https://doi.org/10.1186/s41181-024-00243-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10876507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38372838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Krutzek%20F,%20Donat%20CK,%20Stadlbauer%20S.%20Chelator%20impact:%20investigating%20the%20pharmacokinetic%20behavior%20of%20copper-64%20labeled%20PD-L1%20radioligands.%20EJNMMI%20radiopharm%20chem.%202024;9(1):14." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<cite>Lee I, Kim MH, Lee K, Oh K, Lim H, Ahn JH, et al. Comparison of the effects of DOTA and NOTA chelators on 64Cu-cudotadipep and 64Cu-cunotadipep for prostate cancer. Diagnostics. 2023;13(16):2649.
</cite> [<a href="https://doi.org/10.3390/diagnostics13162649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10453766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37627908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20I,%20Kim%20MH,%20Lee%20K,%20Oh%20K,%20Lim%20H,%20Ahn%20JH,%20et%20al.%20Comparison%20of%20the%20effects%20of%20DOTA%20and%20NOTA%20chelators%20on%2064Cu-cudotadipep%20and%2064Cu-cunotadipep%20for%20prostate%20cancer.%20Diagnostics.%202023;13(16):2649." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<cite>Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Delivery Rev Sept. 2008;60(12):1347–70.</cite> [<a href="https://doi.org/10.1016/j.addr.2008.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2539110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18538888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20S.%20Bifunctional%20coupling%20agents%20for%20radiolabeling%20of%20biomolecules%20and%20target-specific%20delivery%20of%20metallic%20radionuclides.%20Adv%20Drug%20Delivery%20Rev%20Sept.%202008;60(12):1347%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<cite>Mitran B, Thisgaard H, Rinne S, Dam JH, Azami F, Tolmachev V, et al. Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26. Sci Rep. 2019;9(1):17086.
</cite> [<a href="https://doi.org/10.1038/s41598-019-52914-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6863848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31745219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mitran%20B,%20Thisgaard%20H,%20Rinne%20S,%20Dam%20JH,%20Azami%20F,%20Tolmachev%20V,%20et%20al.%20Selection%20of%20an%20optimal%20macrocyclic%20chelator%20improves%20the%20imaging%20of%20prostate%20cancer%20using%20cobalt-labeled%20GRPR%20antagonist%20RM26.%20Sci%20Rep.%202019;9(1):17086." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<cite>Montemagno C, Bacot S, Ahmadi M, Kerfelec B, Baty D, Debiossat M, et al. Preclinical evaluation of mesothelin-specific ligands for SPECT imaging of triple-negative breast cancer. J Nucl Med. 2018;59(7):1056–62.
</cite> [<a href="https://doi.org/10.2967/jnumed.117.203489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29572256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montemagno%20C,%20Bacot%20S,%20Ahmadi%20M,%20Kerfelec%20B,%20Baty%20D,%20Debiossat%20M,%20et%20al.%20Preclinical%20evaluation%20of%20mesothelin-specific%20ligands%20for%20SPECT%20imaging%20of%20triple-negative%20breast%20cancer.%20J%20Nucl%20Med.%202018;59(7):1056%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<cite>Montemagno C, Cassim S, Pouyssegur J, Broisat A, Pagès G. From malignant progression to therapeutic targeting: current insights of mesothelin in pancreatic ductal adenocarcinoma. IJMS. 2020;21(11):4067.
</cite> [<a href="https://doi.org/10.3390/ijms21114067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7312874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32517181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montemagno%20C,%20Cassim%20S,%20Pouyssegur%20J,%20Broisat%20A,%20Pag%C3%A8s%20G.%20From%20malignant%20progression%20to%20therapeutic%20targeting:%20current%20insights%20of%20mesothelin%20in%20pancreatic%20ductal%20adenocarcinoma.%20IJMS.%202020;21(11):4067." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<cite>Montemagno, Cassim, Trichanh, Savary, Pouyssegur, Pagès, et al. 99mTc-A1 as a novel imaging agent targeting mesothelin-expressing pancreatic ductal adenocarcinoma. Cancers. 2019;11(10):1531.</cite> [<a href="https://doi.org/10.3390/cancers11101531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6827014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31658755/" class="usa-link">PubMed</a>]</li>
<li id="CR21">
<cite>Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82(1):775–97.
</cite> [<a href="https://doi.org/10.1146/annurev-biochem-063011-092449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23495938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muyldermans%20S.%20Nanobodies:%20natural%20single-domain%20antibodies.%20Annu%20Rev%20Biochem.%202013;82(1):775%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<cite>N’Guessan É, Raes F, Ahmadi M, Bacot S, Dumas L, Leenhardt J, et al. Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering. EJNMMI Radiopharm Chem. 2025;10(1):19.
</cite> [<a href="https://doi.org/10.1186/s41181-025-00340-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12037457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40293556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?N%E2%80%99Guessan%20%C3%89,%20Raes%20F,%20Ahmadi%20M,%20Bacot%20S,%20Dumas%20L,%20Leenhardt%20J,%20et%20al.%20Enhancing%20theranostic%20potential%20of%20anti-mesothelin%20sdAb%20through%20site-specific%20labeling%20at%20a%20unique%20conserved%20lysine%20by%20molecular%20engineering.%20EJNMMI%20Radiopharm%20Chem.%202025;10(1):19." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<cite>Notni J, Pohle K, Wester HJ. Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. EJNMMI Res. 2012;2(1):28.
</cite> [<a href="https://doi.org/10.1186/2191-219X-2-28" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3538506/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22682112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Notni%20J,%20Pohle%20K,%20Wester%20HJ.%20Comparative%20gallium-68%20labeling%20of%20TRAP-,%20NOTA-,%20and%20DOTA-peptides:%20practical%20consequences%20for%20the%20future%20of%20gallium-68-PET.%20EJNMMI%20Res.%202012;2(1):28." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<cite>Price EW, Orvig C. Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev. 2014;43(1):260–90.
</cite> [<a href="https://doi.org/10.1039/c3cs60304k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24173525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Price%20EW,%20Orvig%20C.%20Matching%20chelators%20to%20radiometals%20for%20radiopharmaceuticals.%20Chem%20Soc%20Rev.%202014;43(1):260%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<cite>Ray Banerjee S, Chen Z, Pullambhatla M, Lisok A, Chen J, Mease RC, et al. Preclinical comparative study of 68Ga-labeled DOTA, NOTA, and HBED-CC chelated radiotracers for targeting PSMA. Bioconjugate Chem. 2016;27(6):1447–55.</cite> [<a href="https://doi.org/10.1021/acs.bioconjchem.5b00679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5290997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27076393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ray%20Banerjee%20S,%20Chen%20Z,%20Pullambhatla%20M,%20Lisok%20A,%20Chen%20J,%20Mease%20RC,%20et%20al.%20Preclinical%20comparative%20study%20of%2068Ga-labeled%20DOTA,%20NOTA,%20and%20HBED-CC%20chelated%20radiotracers%20for%20targeting%20PSMA.%20Bioconjugate%20Chem.%202016;27(6):1447%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<cite>Rottey S, Clarke J, Aung K, Machiels JP, Markman B, Heinhuis KM, et al. Phase I/IIa Trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors. Clinical Cancer Research. 2022;28(1):95–105.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-21-1181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9401510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34615718/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<cite>Weekes CD, Lamberts LE, Borad MJ, Voortman J, McWilliams RR, Diamond JR, et al. Phase I study of DMOT4039A, an antibody–drug conjugate targeting mesothelin, in patients with unresectable pancreatic or platinum-resistant ovarian cancer. Mol Cancer Therap. 2016;15(3):439–47.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-15-0693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26823490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weekes%20CD,%20Lamberts%20LE,%20Borad%20MJ,%20Voortman%20J,%20McWilliams%20RR,%20Diamond%20JR,%20et%20al.%20Phase%20I%20study%20of%20DMOT4039A,%20an%20antibody%E2%80%93drug%20conjugate%20targeting%20mesothelin,%20in%20patients%20with%20unresectable%20pancreatic%20or%20platinum-resistant%20ovarian%20cancer.%20Mol%20Cancer%20Therap.%202016;15(3):439%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<cite>Xavier C, Vaneycken I, D’huyvetter M, Heemskerk J, Keyaerts M, Vincke C, et al. Synthesis, preclinical validation, dosimetry, and toxicity of<sup>68</sup> Ga-NOTA-anti-HER2 nanobodies for iPET imaging of HER2 receptor expression in cancer. J Nucl Med. 2013;54(5):776–84.
</cite> [<a href="https://doi.org/10.2967/jnumed.112.111021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23487015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xavier%20C,%20Vaneycken%20I,%20D%E2%80%99huyvetter%20M,%20Heemskerk%20J,%20Keyaerts%20M,%20Vincke%20C,%20et%20al.%20Synthesis,%20preclinical%20validation,%20dosimetry,%20and%20toxicity%20of68%20Ga-NOTA-anti-HER2%20nanobodies%20for%20iPET%20imaging%20of%20HER2%20receptor%20expression%20in%20cancer.%20J%20Nucl%20Med.%202013;54(5):776%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<cite>Xia Y, Zeng C, Zhao Y, Zhang X, Li Z, Chen Y. Comparative evaluation of 68Ga-labelled TATEs: the impact of chelators on imaging. EJNMMI Res Déc. 2020;10(1):36.</cite> [<a href="https://doi.org/10.1186/s13550-020-00620-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7158967/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32297029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20Y,%20Zeng%20C,%20Zhao%20Y,%20Zhang%20X,%20Li%20Z,%20Chen%20Y.%20Comparative%20evaluation%20of%2068Ga-labelled%20TATEs:%20the%20impact%20of%20chelators%20on%20imaging.%20EJNMMI%20Res%20D%C3%A9c.%202020;10(1):36." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<cite>Zhai X, Mao L, Wu M, Liu J, Yu S. Challenges of anti-mesothelin CAR-T-cell therapy. Cancers. 2023;15(5):1357.
</cite> [<a href="https://doi.org/10.3390/cancers15051357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10000068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36900151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhai%20X,%20Mao%20L,%20Wu%20M,%20Liu%20J,%20Yu%20S.%20Challenges%20of%20anti-mesothelin%20CAR-T-cell%20therapy.%20Cancers.%202023;15(5):1357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<cite>Zhang Y, Hong H, Engle JW, Bean J, Yang Y, Leigh BR, et al. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. Bachmann MP, éditeur. PLoS ONE. 2011;6(12):e28005.</cite> [<a href="https://doi.org/10.1371/journal.pone.0028005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3235104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22174762/" class="usa-link">PubMed</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12367608/bin/41181_2025_380_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (150.5KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from EJNMMI Radiopharmacy and Chemistry are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s41181-025-00380-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41181_2025_Article_380.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12367608/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12367608/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367608%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367608/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12367608/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12367608/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40833585/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12367608/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40833585/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12367608/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12367608/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="D2JOW6OEajl5h8jmiIgI1BL32bU3YU2Kkqy3jeUmI0fuam6r83UizbBmfhB2KPQv">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
